文献速递慢阻肺

基于智能手机应用的肺康复在慢阻肺中的多中心随机对照试验

Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial.
PubMed 文献 · Thorax · 2025-03-18

这项在德国和瑞士18个中心开展的随机对照试验纳入278例慢阻肺患者,评估12周手机应用肺康复对比增强标准治疗的效果。意向性分析显示第12周CAT评分组间差异无统计学意义(差值0分,95%CI -1至2,p=0.7),1分钟坐立试验差异亦无统计学意义(差值1次,95%CI 0至2,p=0.12);应用依从者(40.4%)的1分钟坐立试验较非依从者改善更多(中位2次,95%CI 1至3,p=0.006)。

要点

  • 12周手机应用肺康复对比增强标准治疗,CAT和1分钟坐立试验组间差异均无统计学意义。
  • 应用依从者(40.4%)的1分钟坐立试验较非依从者改善更多,中位差异2次(95%CI 1至3,p=0.006)。
  • 应用使用未引起安全性问题。

核心结论

  • 基于应用的肺康复较基线改善慢阻肺患者结局,依从者运动能力改善优于非依从者。
  • 与增强标准治疗相比差异未达统计学意义,但研究可能支持该应用用于慢阻肺管理并应对肺康复可及性挑战。

研究设计与样本

  • 多中心随机对照试验,在德国和瑞士18个中心招募慢阻肺患者。
  • 278例患者纳入研究,中位年龄65岁(IQR 60-70),第1秒用力呼气容积占预计值48%(IQR 37-60)。
  • 干预组接受12周移动应用,对照组接受增强标准治疗。

主要发现

  • 第12周意向性分析中,CAT评分干预组较基线中位改善-4分,对照组-3分,差值0分(95%CI -1至2),p=0.7。
  • 1分钟坐立试验干预组较基线改善1次,对照组2次,差值1次(95%CI 0至2),p=0.12。
  • 干预组中依从者(40.4%)的1分钟坐立试验较非依从者中位改善2次(95%CI 1至3),p=0.006。
  • 应用使用未引起安全性问题。

临床怎么用

  • 该应用可作为慢阻肺肺康复的可及性补充手段,但需注意依从性与运动能力获益相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary rehabilitation (PR) is an essential element of chronic obstructive pulmonary disease (COPD) management. However, access to conventional face-to-face PR programmes is limited. METHODS: This multicentre, randomised controlled trial recruited patients with COPD from 18 sites in Germany and Switzerland, aiming to evaluate the impact of 12 weeks of a mobile app (intervention group; IVG) on quality of life, measured by COPD Assessment Test (CAT), and exercise capacity, assessed by 1-minute-sit-to-stand-test (1MSTST), compared with a control group (CTG) receiving 'enhanced standard-of-care'. RESULTS: 278 patients were included in the study with a median age of 65 years (IQR 60-70) and forced expiratory volume in 1 s 48% predicted (IQR 37-60). In the intention-to-treat analysis at week 12, CAT improved from baseline by median -4 points versus -3 points in the IVG versus CTG groups, respectively (difference: 0 points (95% CI: -1, 2); p=0.7); 1MSTST improved by 1 vs 2 repetitions, respectively (difference: 1 repetition (95% CI: 0, 2); p=0.12)). In a subset of the IVG, with patients grouped by application adherence (≥3 days/week for≥75% of the weeks), adherent users (40.4%) improved 1MSTST versus non-adherent users by median 2 repetitions (95% CI: 1, 3]; p=0.006. Application use did not raise any safety concerns. CONCLUSIONS: Application-based PR improved outcomes in COPD compared with baseline, and adherent users improved exercise capacity more compared with non-adherent users. Although not statistically significant compared with enhanced standard-of-care, this study may support the use of this application for COPD management and addresses the healthcare challenge of access to PR interventions. TRIAL REGISTRATION NUMBER: DRKS 00024390.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Gloeckl R, Spielmanns M, Stankeviciene A, et al. Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial. Thorax. 2025. PMID: 39706685. doi:10.1136/thorax-2024-221803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。